Cite
Mansour-Ghanaei F, Joukar F, Khalesi AA, et al. Naproxen, isosorbide dinitrate and co-administration cannot prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. Ann Hepatobiliary Pancreat Surg. 2020;24(3):259-268doi: 10.14701/ahbps.2020.24.3.259.
Mansour-Ghanaei, F., Joukar, F., Khalesi, A. A., Naghipour, M., Sepehrimanesh, M., Mojtahedi, K., Yeganeh, S., Saedi, H. S., & Asl, S. F. (2020). Naproxen, isosorbide dinitrate and co-administration cannot prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. Annals of hepato-biliary-pancreatic surgery, 24(3), 259-268. https://doi.org/10.14701/ahbps.2020.24.3.259
Mansour-Ghanaei, Fariborz, et al. "Naproxen, isosorbide dinitrate and co-administration cannot prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial." Annals of hepato-biliary-pancreatic surgery vol. 24,3 (2020): 259-268. doi: https://doi.org/10.14701/ahbps.2020.24.3.259
Mansour-Ghanaei F, Joukar F, Khalesi AA, Naghipour M, Sepehrimanesh M, Mojtahedi K, Yeganeh S, Saedi HS, Asl SF. Naproxen, isosorbide dinitrate and co-administration cannot prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. Ann Hepatobiliary Pancreat Surg. 2020 Aug 31;24(3):259-268. doi: 10.14701/ahbps.2020.24.3.259. PMID: 32843590; PMCID: PMC7452799.
Copy
Download .nbib